Search
for
Sort by
Research 30 of 110
- 127 NDRG1 regulates proliferation of endothelial cells of infantile hemangioma
- All-Cause and Cause-Specific Mortality Risks Associated With Alopecia Areata
- 131 Mutational landscape of extramammary Paget disease
- 129 Genetic transformation of keratoacanthoma-type cutaneous squamous cell carcinoma following intralesional chemotherapy
- Effect of Sun exposure-induced ferroptosis mechanisms on pathology and potential biological processes of primary melanoma by microarray data analysis
- Comparison of Adhesive Tape Impression Cytology, Hair Plucks, and Fungal Culture for the Diagnosis of Dermatophytosis in Dogs and Cats
- Cell/Tissue Microenvironment Engineering and Monitoring in Tissue Engineering, Regenerative Medicine, and In Vitro Tissue Models
- Features of hemorheological disorders in patients with alopecia associated with coronavirus infection
- 130 Expression of nidogen1 in basal cell carcinoma
- 126 cAMP response element-binding protein 1 (CREB) is a β-catenin-regulated transcription factor in squamous cell carcinoma (SCC) cells
- Is the “Comb Over” Dying? A Mouse Model for Male Pattern Baldness (Androgenic Alopecia)
- Hormonal Therapy for Acne
- Finasteride in Androgenic Alopecia
- The effectiveness of treatments for androgenetic alopecia: A systematic review and meta-analysis
- Low-Level Light Therapy for Androgenetic Alopecia: A 24-Week, Randomized, Double-Blind, Sham Device–Controlled Multicenter Trial
- Promotional Effect of Platelet-Rich Plasma on Hair Follicle Reconstitution in vivo
- The expression of insulin-like growth factor 1 in follicular dermal papillae correlates with therapeutic efficacy of finasteride in androgenetic alopecia
- Evaluating the Efficacy of Different Platelet-Rich Plasma Regimens for Management of Androgenetic Alopecia: A Single-Center, Blinded, Randomized Clinical Trial
- A Mouse Model of Androgenetic Alopecia
- Polycystic Ovary Syndrome and Its Differential Diagnosis
- Higher body mass index is associated with greater severity of alopecia in men with male-pattern androgenetic alopecia in Taiwan: A cross-sectional study
- Global photographic assessment of men aged 18 to 60 years with male pattern hair loss receiving finasteride 1 mg or placebo
- Long-term Oral Administration of 5α-reductase Inhibitor Attenuates Erectile Function by Inhibiting Autophagy and Promoting Apoptosis of Smooth Muscle Cells in Corpus Cavernosum of Aged Rats
- Androgenetic alopecia and risk of prostate cancer: A systematic review and meta-analysis
- Hair growth effects of oral administration of finasteride, a steroid 5 alpha-reductase inhibitor, alone and in combination with topical minoxidil in the balding stumptail macaque.
- Long-term treatment with finasteride 1 mg decreases the likelihood of developing further visible hair loss in men with androgenetic alopecia (male pattern hair loss).
- Urinary steroids in women with androgenic alopecia
- Discovery of Natural Steroid 5 Alpha-Reductase Inhibitors
- COMBINATION OF AN ANTIANDROGEN AND A 5α-REDUCTASE INHIBITOR: A FURTHER STEP TOWARDS TOTAL ANDROGEN BLOCKADE?
- Adrenal steroid precursors exert potent androgenic action in the hamster sebaceous glands of flank organs and ears.